AMALY — SHARIAH COMPLIANCE REPORT ================================== Symbol: VOR Report Date: 2026-07-02 Full Report: https://amaly.io/stock/VOR EXECUTIVE SUMMARY ------------------ Compliance Status: NON_COMPLIANT Quality Rating: B Description: VOR, a clinical-stage biotechnology company focused on engineered hematopoietic stem cell therapy, demonstrates a permissible core business activity aligned with Islamic principles of preserving life. However, financial screening reveals challenges with high liquidity ratios exceeding key thresholds across major standards, leading to non-compliance in market cap-based assessments. The company maintains low debt and no identifiable non-permissible income, resulting in no purification requirement. Despite positive ESG factors, the stock is not included in any major Shariah indices, classifying it as NON_COMPLIANT overall. Investors may consider it under review in asset-based methodologies pending further data. Primary Compliance Concerns: - High liquidity ratio of 41.49% exceeds 30-33% thresholds in AAOIFI, S&P, and FTSE standards - Insufficient detailed income statement data for full verification of non-permissible sources - Potential distortion in ratios due to biotech funding structure with high cash reserves Purification Requirement: 0.00% Index Inclusion: Not included in S&P Dow Jones Shariah Indices, MSCI Islamic Indices, FTSE Shariah Indices, or Dow Jones Islamic Market (DJIM) KEY FINANCIAL METRICS ---------------------- Debt Ratio: 21.3% Liquidity Ratio: 41.5% Interest Income Ratio: 0.0% Purification Required: 0.00% INDEX INCLUSION STATUS ----------------------- S&P Shariah: EXCLUDED MSCI Islamic: EXCLUDED DJIM: EXCLUDED FTSE Shariah: EXCLUDED Total: 0 of 4 Last Verified: 2025-12-31 REPORTING PERIOD ----------------- Latest Annual Report: FY 2025 Latest Quarterly Data: Q4 2025 Trend Period: FY 2020 to FY 2025 Data Retrieved: 2026-02-26T00:00:00Z --- Full interactive report: https://amaly.io/stock/VOR Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.